Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage Management After Second-trimester Abortion: A Randomized Clinical Trial

NCT02485444 is registered in ClinicalTrials.gov with Ataturk University as lead sponsor.

NCT NCT02485444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02485444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage Management After Second-trimester Abortion: A Randomized Clinical Trial
Lead sponsor
Ataturk University
Phase
Phase 4
Overall status
Completed
Start date
June 8, 2015
Completion date
June 10, 2016
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abortion, induced, labor stage, third/drug effects, oxytocin/administration & dosage, pregnancy trimester, second